Header Logo

Connection

Glenda Gray to Tenofovir

This is a "connection" page, showing publications Glenda Gray has written about Tenofovir.
Connection Strength

0,467
  1. HIV Incidence Among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP Use. J Acquir Immune Defic Syndr. 2021 12 01; 88(4):376-383.
    View in: PubMed
    Score: 0,179
  2. "It Was Not My Aim to Sleep There": The Impact of Timing and Location of Sex on Adherence to Coitally-Dependent HIV Pre-exposure Prophylaxis. AIDS Behav. 2018 Nov; 22(11):3692-3704.
    View in: PubMed
    Score: 0,144
  3. Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2018 11; 18(11):1241-1250.
    View in: PubMed
    Score: 0,144
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.